In patients with coronary artery disease, DynamX® is associated with lower rates of target vessel myocardial infarction and target vessel failure.

Black and Hispanic patients with preeclampsia are less likely to receive postpartum primary care or cardiology follow-up within 1 year after delivery.

Among publicly insured individuals, those in a historically marginalized group are less likely to initiate biologics prescribed for severe asthma or other indications.

An examination of the cardiovascular risks, side effects associated with use of lecanemab therapy in patients with cardiovascular disease.

The prevalence of obesity among adults was 40.3 percent during August 2021 to August 2023, according to a data brief.

Liver stiffness measurement progression is associated with type 2 diabetes and HbA1c among patients with MASLD.

Semaglutide for obesity was associated with superior weight reduction and glycemic control among patients with obesity and prediabetes.